ONABOTULINUMTOXINA HAS A POSITIVE SAFETY AND EFFICACY PROFILE IN OVERACTIVE BLADDER (OAB) PATIENTS <65 AND ≥65 YEARS OF AGE

被引：0
|
作者：
Moore, Courtenay [1 ]
Kaufmann, Albert [2 ]
Joshi, Manher [3 ]
Zheng, Yan [4 ]
Herschorn, Sender [5 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Kliniken Maria Hilf GmbH, Monchengladbach, Germany
[3] Allergan Pharmaceut Inc, Irvine, CA USA
[4] Allergan Pharmaceut Inc, Bridgewater, NJ USA
[5] Univ Toronto, Toronto, ON, Canada
来源：
NEUROUROLOGY AND URODYNAMICS | 2015年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
34
引用
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
  • [21] A pooled analysis of the efficacy of fesoterodine for the treatment of overactive bladder, and the relationship between safety, co-morbidity and polypharmacy in patients aged 65 years or older
    Wagg, Adrian
    Arumi, Daniel
    Herschorn, Sender
    Angulo Cuesta, Javier
    Haab, Francois
    Ntanios, Fady
    Carlsson, Martin
    Oelke, Matthias
    AGE AND AGEING, 2017, 46 (04) : 620 - 626
  • [22] SAFETY AND EFFICACY OF EZETIMIBE/SIMVASTATIN COMBINATION VERSUS ATORVASTATIN IN PATIENTS 65 YEARS OF AGE AND OLDER
    Foody, J. M.
    Brown, W. V.
    Zieve, F.
    Adewale, A. J.
    Flaim, D.
    Lowe, R. S.
    Jones-Burton, C.
    Tershakovec, A. M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 75 - 76
  • [23] Comparison of clinical characteristics and outcomes of pyogenic liver abscess patients<65years of age versus65years of age
    Zhang, Jia
    Du, Zhaoqing
    Bi, Jianbin
    Wu, Zheng
    Lv, Yi
    Zhang, Xufeng
    Wu, Rongqian
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [24] Efficacy of Amlodipine/Olmesartan Medoxomil ± Hydrochlorothiazide in Patients Aged ≥ 65 or < 65 Years With Uncontrolled Hypertension on Prior Monotherapy
    Weir, Matthew R.
    Shojaee, Ali
    Maa, Jen-Fue
    POSTGRADUATE MEDICINE, 2013, 125 (02) : 124 - 134
  • [25] Duloxetine for the management of diabetic peripheral neuropathic pain:: Comparison of safety data in older (age ≥65) and younger (age <65) patients
    Robinson, M
    Rosen, A
    Hardy, T
    Shen, S
    Wernicke, JF
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S128 - S128
  • [26] Efficacy and safety of onabotulinumtoxinA injection in patients with refractory overactive bladder: First multicentric study in Turkish population
    Onem, Kadir
    Bayrak, Omer
    Demirtas, Abdullah
    Coskun, Burhan
    Dincer, Murat
    Kocak, Izzet
    Onur, Rahmi
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 (01) : 263 - 268
  • [27] EFFICACY AND SAFETY OF ROMIPLOSTIM IN PATIENTS ≥65 YEARS WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Michel, M.
    Wasser, J.
    Godeau, B.
    Aledort, L.
    Cooper, N.
    Tomiyama, Y.
    Khellaf, M.
    Wang, X.
    Woodard, P.
    HAEMATOLOGICA, 2013, 98 : 196 - 196
  • [28] Accumulation of Chronic Conditions in Patients <65 Years of Age Diagnosed With Atrial Fibrillation
    Chamberlain, Alanna M.
    Alonso, Alvaro
    Noseworthy, Peter A.
    Gersh, Bernard J.
    Manemann, Sheila M.
    Weston, Susan
    Killian, Jill
    Ryu, Euijung
    Roger, Veronique L.
    Siontis, Konstantinos
    CIRCULATION, 2023, 148
  • [29] Increased mortality after lower extremity fractures in patients <65 years of age
    Somersalo, Axel
    Paloneva, Juha
    Kautiainen, Hannu
    Lonnroos, Eija
    Heinanen, Mikko
    Kiviranta, Ilkka
    ACTA ORTHOPAEDICA, 2016, 87 (06) : 622 - 625
  • [30] SAFETY AND EFFICACY CONCERNS IN SWITCHING PATIENTS WITH OVERACTIVE BLADDER (OAB) SYMPTOMS FROM BRANDED TO GENERIC ANTICHOLINERGIC MEDICATIONS
    Kaplan, Steven A.
    Chung, Doreen E.
    Sandhu, Jaspreet S.
    Te, Alexis E.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 675 - 675
12345